Omnicell, Inc. (OMCL) Stock Analysis
Free AI-powered analysis and research for Omnicell, Inc. stock
Sector: Healthcare
Full OMCL report
Omnicell, Inc. (OMCL) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze OMCL Now βπ° Latest Update
Omnicellβs Q3 earnings call: our top 5 analyst questions
Mon, November 2, 2026 at 3:25 PM UTC 4 min read
Omnicell reported third-quarter earnings of $307.9 million, slightly exceeding analyst estimates, with an adjusted EPS of $0.58, significantly beating expectations. CEO Randall Lipps emphasized the company's strong engagement with health systems and the growing importance of automation in medication management. Despite flat sales, Omnicell's operational efficiency and expanding leasing programs contributed to improved margins, while management raised its full-year adjusted EPS guidance to $2.52.